SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-06-056647
Filing Date
2006-03-16
Accepted
2006-03-16 15:51:27
Documents
9
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 780146
2 NON-EMPLOYEE DIRECTOR COMPENSATION SUMMARY dex1049.htm EX-10.49 15798
3 2005 STOCK PLAN NOTICE OF RESTRICTED STOCK GRANT dex1054.htm EX-10.54 42053
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 3942
5 CERTIFICATION dex311.htm EX-31.1 10292
6 CERTIFICATION dex312.htm EX-31.2 10375
7 CERTIFICATION dex321.htm EX-32.1 3336
8 CERTIFICATION dex322.htm EX-32.2 3374
9 GRAPHIC g45556g24e57.jpg GRAPHIC 12207
  Complete submission text file 0001193125-06-056647.txt   887751
Mailing Address 1700 PERIMETER PARK DRIVE MORRISVILLE NC 27560
Business Address 1700 PERIMETER PARK DRIVE MORRISVILLE NC 27560 (919) 862-1000
SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

IRS No.: 943267443 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23265 | Film No.: 06691930
SIC: 2834 Pharmaceutical Preparations